<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>Xconomy &#187; Embryome Sciences</title>
	<atom:link href="http://www.xconomy.com/tag/embryome-sciences/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com</link>
	<description>Business + Technology in the Exponential Economy</description>
	<pubDate>Sun, 22 Nov 2009 19:59:19 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>ACT Licences Pluropotent Cell IP</title>
		<link>http://www.xconomy.com/boston/2008/08/21/act-licences-pluropotent-cell-ip/</link>
		<pubDate>Fri, 22 Aug 2008 01:57:55 +0000</pubDate>
		<dc:creator>Ryan McBride</dc:creator>
				<category><![CDATA[Boston]]></category>
		<category><![CDATA[Boston briefs]]></category>
		<category><![CDATA[deals]]></category>
		<category><![CDATA[Advanced Cell Technology]]></category>
		<category><![CDATA[Embryome Sciences]]></category>
		<category><![CDATA[Stem Cells]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=4459</guid>
		<description><![CDATA[Advanced Cell Technology, a California-based developer of cellular treatments with R&#38;D labs in Worcester, MA, has licensed technology from Embryome Sciences related to the reprogramming of human cells such as skin cells into embryonic-like cells that can differentiate into a variety of cell types, Embryome reports. The technology from Alameda, CA-based Embryome is intended to [...]]]></description>
			<content:encoded><![CDATA[ 
		<div style="text-transform:uppercase"><a href="http://www.xconomy.com/tag/deals/">deals</a>, <a href="http://www.xconomy.com/tag/Advanced-Cell-Technology/">Advanced Cell Technology</a>, <a href="http://www.xconomy.com/tag/embryome-sciences/">Embryome Sciences</a></div>
		 
		<strong>Ryan McBride wrote:</strong>
		<p>Advanced Cell Technology, a California-based developer of cellular treatments with R&amp;D labs in Worcester, MA, has licensed technology from Embryome Sciences related to the reprogramming of human cells such as skin cells into embryonic-like cells that can differentiate into a variety of cell types, <a href="http://www.businesswire.com/portal/site/home/template.NDM/news/more/?javax.portlet.tpst=0b2c9a4dd5f89b80977dd367cc87b42f_ws_MX&amp;javax.portlet.prp_0b2c9a4dd5f89b80977dd367cc87b42f_viewID=news_view_popup&amp;javax.portlet.prp_0b2c9a4dd5f89b80977dd367cc87b42f_newsLang=en&amp;javax.portlet.prp_0b2c9a4dd5f89b80977dd367cc87b42f_ndmHsc=v2*A1216724400000*B1219369462000*DgroupByDate*J2*L1*N1000837*ZAdvanced%20Cell%20Technology&amp;javax.portlet.prp_0b2c9a4dd5f89b80977dd367cc87b42f_newsId=20080821005358&amp;beanID=202776713&amp;viewID=news_view_popup&amp;javax.portlet.begCacheTok=com.vignette.cachetoken&amp;javax.portlet.endCacheTok=com.vignette.cachetoken">Embryome reports</a>. The technology from Alameda, CA-based Embryome is intended to enable cells with stem cell-like qualities to be generated without the controversial use of human embryos and egg cells.</p>
		<div class="postFooter"><a href="http://www.xconomy.com/boston/2008/08/21/act-licences-pluropotent-cell-ip/#comments">Comments</a> | <a href=http://www.xconomy.com/reprints/>Reprints</a> | Share: &nbsp;
<a href="http://twitter.com/home?status=RT @Xconomy ACT Licences Pluropotent Cell IP http://xconomy.com/?p=4459" target="_blank" rel="nofollow"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/twitter.gif" alt="Retweet"/></a>
&nbsp;<a href="http://www.facebook.com/sharer.php?u=http://www.xconomy.com/boston/2008/08/21/act-licences-pluropotent-cell-ip/&t=ACT Licences Pluropotent Cell IP" target="_blank" rel="nofollow"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/facebook.gif" alt="Facebook"/></a>
&nbsp;<a href=http://www.xconomy.com/boston/2008/08/21/act-licences-pluropotent-cell-ip/email/ target="_blank" rel="nofollow"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/email.gif" alt="Email"/></a>
&nbsp;<a href="http://sharethis.com/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=ACT+Licences+Pluropotent+Cell+IP&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2008%2F08%2F21%2Fact-licences-pluropotent-cell-ip%2F"><img src="http://www.xconomy.com/wordpress/wp-content/themes/xconomy/images/share.gif" alt="Share"/></a>
</div>			
	     			<br>UNDERWRITERS AND PARTNERS<br>
						<a href='http://d1.openx.org/ck.php?zoneid=77968' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77968&amp;source=national_&amp;cb=425' border='0' alt='' /></a>
							<a href='http://d1.openx.org/ck.php?zoneid=77967' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77967&amp;source=national_&amp;cb=886' border='0' alt='' /></a>
							<a href='http://d1.openx.org/ck.php?zoneid=77969' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77969&amp;source=national_&amp;cb=148' border='0' alt='' /></a>
						<br/>
							<a href='http://d1.openx.org/ck.php?zoneid=77972' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77972&amp;source=national_&amp;cb=819' border='0' alt='' /></a>
							<a href='http://d1.openx.org/ck.php?zoneid=77971' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77971&amp;source=national_&amp;cb=97' border='0' alt='' /></a>
							<a href='http://d1.openx.org/ck.php?zoneid=77970' target='_blank'>
				<img src='http://d1.openx.org/avw.php?zoneid=77970&amp;source=national_&amp;cb=639' border='0' alt='' /></a>
									]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/boston/2008/08/21/act-licences-pluropotent-cell-ip/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

 
